266 related articles for article (PubMed ID: 6140962)
1. Neuroleptic-induced reductions in serum dopamine-beta-hydroxylase in schizophrenia.
Goodnick PJ; Tong C; Duncavage MB; Meltzer HY
Biol Psychiatry; 1983 Dec; 18(12):1485-8. PubMed ID: 6140962
[No Abstract] [Full Text] [Related]
2. Neuroleptic drug effect on plasma dopamine-beta-hydroxylase in schizophrenia.
Baron M; Gruen R; Levitt M; Kane J
Neuropsychobiology; 1982; 8(6):312-4. PubMed ID: 6131392
[TBL] [Abstract][Full Text] [Related]
3. Dopamine antagonism by thioridazine in schizophrenia.
Meltzer HY; Sachar EJ; Frantz AG
Biol Psychiatry; 1975 Feb; 10(1):53-7. PubMed ID: 1120175
[TBL] [Abstract][Full Text] [Related]
4. Neuroleptic drugs and erythrocyte catechol-O-methyltransferase in schizophrenia.
Baron M; Gruen R; Levitt M; Kane J
Biol Psychiatry; 1982 Nov; 17(11):1339-42. PubMed ID: 6129906
[No Abstract] [Full Text] [Related]
5. An effect of neuroleptic medication on plasma dopamine-beta-hydroxylase activity.
DeLisi LE; Phelps BH; Wise CD; Apostoles PS; Bigelow L; Wyatt RJ
Biol Psychiatry; 1981 Sep; 16(9):873-8. PubMed ID: 6117334
[No Abstract] [Full Text] [Related]
6. [Comparative studies of the effects of perazine, fluphenazine, trifluoperazine, chlorpromazine and haloperidol on primary and deficit symptoms of paranoid schizophrenia].
Termińska K; Mrowiec W
Psychiatr Pol; 1989; 23(1):24-30. PubMed ID: 2573098
[TBL] [Abstract][Full Text] [Related]
7. Maintenance antipsychotic drugs do prevent relapse: a reply to Tobias and MacDonald.
Davis JM; Gosenfeld L; Tsai CC
Psychol Bull; 1976 May; 83(3):431-47. PubMed ID: 6986
[No Abstract] [Full Text] [Related]
8. Tolerance to the prolactin-elevating effect of neuroleptics.
Brown WA; Laughren TP
Psychiatry Res; 1981 Dec; 5(3):317-22. PubMed ID: 6119716
[TBL] [Abstract][Full Text] [Related]
9. Low serum neuroleptic levels predict relapse in schizophrenic patients.
Brown WA; Laughren T; Chisholm E; Williams BW
Arch Gen Psychiatry; 1982 Sep; 39(9):998-1000. PubMed ID: 6126172
[TBL] [Abstract][Full Text] [Related]
10. Serum dopamine-beta-hydroxylase activity in schizophrenia.
Meltzer HY; Nasr SJ; Tong C
Biol Psychiatry; 1980 Oct; 15(5):781-8. PubMed ID: 6106516
[TBL] [Abstract][Full Text] [Related]
11. Are antipsychotic drugs interchangeable?
Gardos G
J Nerv Ment Dis; 1974 Nov; 159(5):343-8. PubMed ID: 4612111
[No Abstract] [Full Text] [Related]
12. Schizophrenia.
Lawrie S; McIntosh A; Nadeem Z
Clin Evid; 2005 Dec; (14):1306-30. PubMed ID: 16620456
[No Abstract] [Full Text] [Related]
13. Implications of phenothiazine side effects: a study of antiparkinsonian agents in an older population.
Martin IC
Acta Psychiatr Scand; 1975 Feb; 51(2):110-8. PubMed ID: 235189
[TBL] [Abstract][Full Text] [Related]
14. Impact of clinical pharmacokinetics on neuroleptic therapy in patients with schizophrenia.
Midha KK; Hubbard JW; Marder SR; Marshall BD; Van Putten T
J Psychiatry Neurosci; 1994 Jul; 19(4):254-64. PubMed ID: 7918346
[TBL] [Abstract][Full Text] [Related]
15. Neurochemical studies on tardive dyskinesia. II. Urinary methoxyhydroxyphenylglycol and plasma dopamine-beta-hydroxylase.
Markianos M; Tripodianakis J; Garelis E
Biol Psychiatry; 1983 Mar; 18(3):347-54. PubMed ID: 6132626
[TBL] [Abstract][Full Text] [Related]
16. Drug induced dystonia tarda: treatment with L-dopa.
Keegan DL; Rajput AH
Dis Nerv Syst; 1973 Mar; 34(3):167-9. PubMed ID: 4146031
[No Abstract] [Full Text] [Related]
17. Neuroleptic drug effect on platelet monoamine oxidase and plasma amine oxidase in schizophrenia.
Baron M; Gruen R; Levitt M; Kane J
Psychiatry Res; 1982 Oct; 7(2):179-87. PubMed ID: 6128754
[TBL] [Abstract][Full Text] [Related]
18. Effects of antipsychotic drugs on memory functions of schizophrenic patients.
Eitan N; Levin Y; Ben-Artzi E; Levy A; Neumann M
Acta Psychiatr Scand; 1992 Jan; 85(1):74-6. PubMed ID: 1347670
[TBL] [Abstract][Full Text] [Related]
19. Efficacy of neuroleptic medication in pervasive developmental disorders of childhood.
Mikkelsen EJ
Schizophr Bull; 1982; 8(2):320-32. PubMed ID: 6126001
[TBL] [Abstract][Full Text] [Related]
20. [Predicting the effect of psychopharmacotherapy in schizophrenic patients].
Dikiĭ NT
Zh Nevropatol Psikhiatr Im S S Korsakova; 1982; 82(1):110-5. PubMed ID: 6121436
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
